-
Notice of Upcoming Funding Opportunity: 2019 Platform Support Grants
https://braincanada.ca/about/news-updates/notice-of-upcoming-funding-opportunity-2019-platform-support-grantsThe Brain Canada Foundation is pleased to announce the second funding opportunity to arise from the $40 million committed by the Government of Canada in Budget 2019. Building off the success of past competitions, the 2019 Platform Support Grants (PSG) competition will be formally launched...
-
Notice of Upcoming Funding Opportunity: 2020 Future Leaders in Canadian Brain Research
https://braincanada.ca/about/news-updates/notice-of-upcoming-funding-opportunity-2020-future-leaders-in-canadian-brain-researchBrain Canada Foundation is pleased to announce a new funding opportunity to support early career researchers. With funding to start in 2021, the 2020 Future Leaders in Canadian Brain Research Grants Program will be formally launched later in October 2020 with a Request for Applications including...
-
Notice of Upcoming Funding Opportunity: 2020 Future Leaders in Canadian Brain Research
https://braincanada.ca/about/news-updates/notice-of-upcoming-funding-opportunity-2020-future-leaders-in-canadian-brain-research-2Brain Canada Foundation is pleased to announce a new funding opportunity to support early career researchers. With funding to start in 2021, the 2020 Future Leaders in Canadian Brain Research Grants Program will be formally launched later in October 2020 with a Request for Applications including...
-
Notice to our research community on COVID-19
https://braincanada.ca/about/news-updates/notice-to-our-research-community-on-covid-19Brain Canada is monitoring COVID-19 and understands the impact it is having on the research community. If you currently hold a Brain Canada grant and anticipate that your research project may be delayed due to COVID-19, please contact us at programs@braincanada.ca. We will work with our funded...
-
Novel approaches to central nervous system white matter repair
https://braincanada.ca/funded-grants/novel-approaches-to-central-nervous-system-white-matter-repairMany nerve cells in the body are covered with a protective sheath known as myelin, which allows fast conduction of nerve impulses, and which is produced by two different types of cells called oligodendrocytes and Schwann cells. Project Overview Many nerve cells in the body are covered with a...
-
Novel approaches to early detection and treatment of ASD
https://braincanada.ca/funded-grants/novel-approaches-to-early-detection-and-treatment-of-asdMore than 1 in 100 individuals are diagnosed with Autism Spectrum Disorder (ASD), with profound impacts on the quality of life of those who are affected and their families. Project Overview More than 1 in 100 individuals are diagnosed with Autism Spectrum Disorder (ASD), with profound impacts on...
-
Novel approaches to understand the role of cAMP and co-signaling cascades in synaptic plasticity and brain disorders
https://braincanada.ca/funded-grants/novel-approaches-to-understand-the-role-of-camp-and-co-signaling-cascades-in-synaptic-plasticity-and-brain-disordersSynaptic plasticity is the process where the strength of connections between nerve cells is altered by experience. Project Overview Synaptic plasticity is the process where the strength of connections between nerve cells is altered by experience. It is widely believed that synaptic plasticity is...
-
Novel biological agents in the treatment of amyotrophic lateral sclerosis based on progranulin/granulin structure
https://braincanada.ca/funded-grants/novel-biological-agents-in-the-treatment-of-amyotrophic-lateral-sclerosis-based-on-progranulin-granulin-structureChallenge: ALS (amyotrophic lateral sclerosis) is an incurable and invariably fatal motor neuron (MN) disease. Project Overview Challenge: ALS (amyotrophic lateral sclerosis) is an incurable and invariably fatal motor neuron (MN) disease. Our challenge is to develop a biologic-therapy that slows,...
-
Novel biomarkers of SOD1 pathology in familial and sporadic ALS
https://braincanada.ca/funded-grants/novel-biomarkers-of-sod1-pathology-in-familial-and-sporadic-alsMutations in the SOD1 gene, leading to the misfolding and toxic aggregation of SOD1 protein, are the second leading cause of Familial Amyotrophic Lateral Sclerosis (FALS-SOD1) and emerging literature has detected misfolded SOD1 (mSOD1) in the cerebrospinal fluid (CSF) and post-mortem tissue of...
-
Novel blood and neuroimaging markers of Alzheimer’s disease and cerebral amyloid angiopathy
https://braincanada.ca/funded-grants/novel-blood-and-neuroimaging-markers-of-alzheimer-s-disease-and-cerebral-amyloid-angiopathyAs our brains age, they become vulnerable to diseases such as Alzheimer’s disease which can cause dementia. Project Overview As our brains age, they become vulnerable to diseases such as Alzheimer’s disease which can cause dementia. Dementia is defined as cognitive (i.e., thinking) problems that...